Comparison of generic-to-brand switchback patterns for generic and authorized generic drugs

類似資料

• Comparison of outcomes following a switch from a brand to an authorized vs. independent generic drug
  著者:: Hansen, Richard A., 等
  出版事項: (2017)
• Brand vs. generic adverse event reporting patterns: an authorized generic-controlled evaluation of cardiovascular medications
  著者:: Alatawi, Yasser, 等
  出版事項: (2017)
• Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
  著者:: Desai, Rishi J, 等
  出版事項: (2018)
• Methodological considerations for comparison of brand versus generic versus authorized generic adverse event reports in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)
  著者:: Rahman, Md. Motiur, 等
  出版事項: (2017)
• Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic Utilization
  著者:: Alderfer J, 等
  出版事項: (2022-04-01)